Medicare coverage for FDA-designated breakthrough medical devices will have to wait, despite broad support.
The Centers for Medicare and Medicaid Services (CMS) issued a final rule in January granting coverage for breakthrough devices the same day as their FDA approvals. The rule was supposed to take effect March 12, but CMS has postponed the Medicare Coverage of Innovative Technology (MCIT) final rule by 60 days to give the public more opportunities to comment, the agency said in a Federal Register notice.
Get the full story on our sister site, Medical Design & Outsourcing.